Union for International Cancer Control (UICC) posted on LinkedIn:
“Antimicrobial Resistance (AMR) is a growing global threat, with serious implications for cancer care. Infections are a leading cause of complications for people undergoing treatment, yet the rise of drug-resistant infections is making effective care increasingly challenging.
In The ASCO Post, Shalini Jayasekar Zurn, Senior Advocacy Manager at UICC, highlights the urgent need for coordinated global action to address AMR and protect the future of cancer treatment.
Read more about how the cancer community can respond.”